Role of Saphenoperitoneal Shunt in Management of Refractory Ascites

Saif Eldin Mohammed Ali Ibrahim, Hanafiah Harunrashid

Abstract


Refractory ascites is difficult to treat by restriction of salt and repeated paracentesis which have been the mainstay of treating it for a long time. Sapheno-peritoneal shunts have been performed in patients with refractory ascites . Here, we evaluated the use of saphenous vein to be anastomosed to the peritoneam to drain the refractory ascites. Nine patients (7 male, median age 45 years, range 17 - 69) with tense refractory ascites associated with liver cirrhosis, perioprtal fibrosis and end stage renal diseases underwent sapheno-peritoneal anastomosis by mobilizing and rotating the proximal vein in order to be anastomosed to peritoneum in the lower abdomen . All procedures were performed under local anaesthesia. Thirty-day mortality was 22% (2) patient. Morbidity included fluid leakage in 1 (11%), and wound infection in 1 (11%). Hospital stay (median) was 16 days (range 11 to 23). In the short term (median of 2 months) significant reduction in body weight and abdominal girth was seen in 9 (90%), 6 (60%) were not on diuretics while 3 (30%) continued to remain on reduced doses of diuretic. Furthermore, 7 (70%) did not require paracentesis. At 2-year follow-up, 5 (45%) patients died and 3 succumbed during follow-up. The remaining 3 were all in active employment, 1 was off diuretics, and 2 were on reduced doses. All 3 patients maintained reduced body weights and abdominal girths compared with preoperative values. Saphenous-peritoneal shunt appears a simple, safe, and cost effective method of achieving long-term control of refractory ascites. The use of autogenous shunt is an added advantage over prosthetic shunts for drainage of ascitic fluid.

Keywords


Ascites, sapheno-peritoneal shunt, anastomoses, peritoneum, abdomen.

Full Text:

PDF

References


Le Veen HH, Christoudias G, Moon IP. Peritoneovenous shunting for ascites. Ann Surg. 1974;180(4):580–590.

Hillaire S, Labianca M, Borgonovo G. Peritoneovenous shunting of intractable ascites in patients with cirrhosis: Improving results and predictive factors of failure. Surgery.1993; 113(4):373–379.

Elcheroth J, Vons C, Franco D. Role of surgical therapy in management of intractable ascites. World J Surg. 1994; 18(2):240–245.

Zervos EE, Rosemurgy AS. Management of medically refractory ascites. Am J Surg.2001; 181(3):256–264.

Lund RH, Newkirk JB. Peritoneovenous shunting system for surgical management of ascites. Contemp Surg. 1979; 14:31–45.

Lund RH, Mortitz MW. Complications of Denver peritoneovenous shunting. Arch Surg.1982; 117(7):924–928.

Valdeyar HJ, Doran DJ, Charnley R, Ryder SD. Saphenoperitoneal shunts for patients with intractable ascites associated with chronic liver disease. Br J Surg.1999; 86(7):882–885.

Petr Utíkal, Petr Dráč, Petr Bachledaa, Jiří Klein. Peritoneosaphenous shunt, modification with the use of long sapheous vein. Biomedial papers. 2004; 148(1):89-90.

Mohamed M.Essawy, Hisham R. El-Khayat.

Evaluation of peritoneovenous Denever shunt in the management of intractable non malignant hepatic ascites. EJS. 2001;20(4):783-794.


Refbacks

  • There are currently no refbacks.


e-issn 2231-7481